Kosei Hasegawa
Saitama Medical University(JP)
Publications by Year
Research Areas
Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Cancer Immunotherapy and Biomarkers, Sarcoma Diagnosis and Treatment, Uterine Myomas and Treatments
Most-Cited Works
- → Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer(2021)939 cited
- → Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial(2024)313 cited
- → First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826(2023)200 cited
- → Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial(2023)184 cited
- → Genomics to immunotherapy of ovarian clear cell carcinoma: Unique opportunities for management(2018)148 cited
- → Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma(2019)147 cited